InElaiabyLouisa Mesnard·May 6, 2021Shift Technology offers Elaia a unicorn hat trickBy Philippe Gire & Louisa Mesnard
InElaiabyLouisa Mesnard·Apr 22, 2021Ornikar: the art of disruption, the talent of executionBy Philippe Gire & Louisa MesnardA response icon1A response icon1
InElaiabyLouisa Mesnard·Oct 15, 2020Where to invest post Covid? A VC take on the hottest sectorsWhat are the next hot topics? This multi billion dollar question is on everybody’s lips ; experts’ opinions vary. Our crystal ball at…
InElaiabyLouisa Mesnard·Jul 10, 2020Doing our job while weathering the crisisAs for everyone else, this troubled period has been intense at Elaia. However, we feel very lucky to have been able to keep working with…
InElaiabyLouisa Mesnard·May 27, 2020Will you be the winner, the survivor or the casualty?This article is based on a series of talks and interviews with Xavier Lazarus, managing partner at Elaia, which were given during the…A response icon1A response icon1
InElaiabyLouisa Mesnard·Jul 11, 2019What does Investing in Biotech really mean?Biotech is one of the strangest, sexiest and scariest industry in the world!
InElaiabyLouisa Mesnard·Apr 29, 2019The story behind the quickest investment we ever made: FretlinkFretlink just announced a major round of investment of €25m so we figured now was a good time to flashback on why we believe in this…
InElaiabyLouisa Mesnard·Apr 3, 2019SeqOne: making genomic medicine accessible to everyoneWe are delighted to announce our investment in SeqOne, one of the sexiest cloud-based biotech companies!
InElaiabyLouisa Mesnard·Mar 14, 2019Yes, you can earn big money with venture capital (even when going through a couple of economical…Actual performance is very secretive in Venture Capital, and Private Equity, generally speaking. Some would say that it’s a confidential…
InElaiabyLouisa Mesnard·Mar 8, 2019[EN] What a journey, growing from seed to series C!This past week, both Mirakl and Shift Technology have announced major investment rounds. We, at Elaia, figured it was a good time to share…A response icon1A response icon1